Diagnosis and treatment in anhidrotic ectodermal dysplasia with immunodeficiency

Allergology International

Volumn 61, Issue 2, 2012, Pages 207-217

  Kawai, Tomoki ^a   Nishikomori, Ryuta ^a   Heike, Toshio ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anhidrotic ectodermal dysplasia with immunodeficiency; Immunodeficiency; Inflammation; NEMO; NF kappaB inhibitor alpha

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; I KAPPA B ALPHA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ZINC FINGER PROTEIN;

ALBERS SCHOENBERG DISEASE; ANHIDROTIC ECTODERMAL DYSPLASIA WITH IMMUNODEFICIENCY; ATYPICAL MYCOBACTERIOSIS; AUTOIMMUNITY; BACTERIAL INFECTION; CARDIOVASCULAR MALFORMATION; CLINICAL FEATURE; EARLY DIAGNOSIS; HUMAN; HYPOHIDROTIC ECTODERMAL DYSPLASIA; IMMUNE DEFICIENCY; INFECTION SENSITIVITY; INFLAMMATORY DISEASE; MYCOBACTERIUM AVIUM; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PHOSPHORYLATION; REVIEW; VIRUS INFECTION;

EID: 84862666587     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.12-RAI-0446     Document Type: Review

References (43)

1. Pinheiro M, Freire-Maia N. Ectodermal dysplasias: a clinical classification and a causal review. Am J Med Genet 1994;53:153-62.
2. Abinun M, Spickett G, Appleton AL, Flood T, Cant AJ. Anhidrotic ectodermal dysplasia associated with specific antibody deficiency. Eur J Pediatr 1996;155:146-7.
3. Sitton JE, Reimund EL. Extramedullary hematopoiesis of the cranial dura and anhidrotic ectodermal dysplasia. Neuropediatrics 1992;23:108-10.
4. Abinun M. Ectodermal dysplasia and immunodeficiency. Arch Dis Child 1995;73:185.
5. Döffinger R, Smahi A, Bessia C et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 2001;27:277-85.
6. Orange JS, Jain A, Ballas ZK, Schneider LC, Geha RS, Bonilla FA. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J Allergy Clin Immunol 2004;113: 725-33.
7. Courtois G, Smahi A, Reichenbach J et al. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 2003;112:1108-15.
8. Frix CD 3rd, Bronson DM. Acute miliary tuberculosis in a child with anhidrotic ectodermal dysplasia. Pediatr Dermatol 1986;3:464-7.
9. Jain A, Ma CA, Liu S, Brown M, Cohen J, Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2001;2:223-8.
10. Mansour S, Woffendin H, Mitton S et al. Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection. Am J Med Genet 2001;99:172-7.
11. Hanson EP, Monaco-Shawver L, Solt LA et al. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol 2008; 122:1169-77.
12. Janssen R, van Wengen A, Hoeve MA et al. The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes. J Exp Med 2004; 200:559-68.
13. McDonald DR, Mooster JL, Reddy M, Bawle E, Secord E, Geha RS. Heterozygous N-terminal deletion of IkappaBalpha results in functional nuclear factor kappaB haploinsufficiency, ectodermal dysplasia, and immune deficiency. J Allergy Clin Immunol 2007;120:900-7.
14. Lopez-Granados E, Keenan JE, Kinney MC et al. A novel mutation in NFKBIA/IKBA results in a degradationresistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency. Hum Mutat 2008;29:861-8.
15. Ohnishi H, Miyata R, Suzuki T et al. A rapid screening method to detect autosomal-dominant ectodermal dysplasia with immune deficiency syndrome. J Allergy Clin Immunol 2012;129:578-80.
16. Courtois G. The NF-kappaB signaling pathway in human genetic diseases. Cell Mol Life Sci 2005;62:1682-91.
17. Razani B, Reichardt AD, Cheng G. Non-canonical NFkappaB signaling activation and regulation: principles and perspectives. Immunol Rev 2011;244:44-54.
18. Yamaoka S, Courtois G, Bessia C et al. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 1998;93: 1231-40.
19. Hubeau M, Ngadjeua F, Puel A et al. New mechanism of X-linked anhidrotic ectodermal dysplasia with immunodeficiency: impairment of ubiquitin binding despite normal folding of NEMO protein. Blood 2011;118:926-35.
20. Vinolo E, Sebban H, Chaffotte A et al. A point mutation in NEMO associated with anhidrotic ectodermal dysplasia with immunodeficiency pathology results in destabilization of the oligomer and reduces lipopolysaccharide-and tumor necrosis factor-mediated NF-kappa B activation. J Biol Chem 2006;281:6334-48.
21. Cordier F, Grubisha O, Traincard F, Veron M, Delepierre M, Agou F. The zinc finger of NEMO is a functional ubiquitin-binding domain. J Biol Chem2009;284:2902-7.
22. Hadian K, Griesbach RA, Dornauer S et al. NF-kappaB essential modulator (NEMO) interaction with linear and lys-63 ubiquitin chains contributes to NF-kappaB activation. J Biol Chem 2011;286:26107-17.
23. Smahi A, Courtois G, Vabres P et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 2000;405:466-72.
24. Zonana J, Elder ME, Schneider LC et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet 2000;67:1555-62.
25. Dupuis-Girod S, Corradini N, Hadj-Rabia S et al. Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics 2002;109:e97.
26. Darwech I, Otero J, Alhawagri M, Dai S, Abu-Amer Y. Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis. J Cell Biochem 2009;108:1337-45.
27. Jain A, Ma CA, Lopez-Granados E et al. Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation. J Clin Invest 2004;114:1593-602.
28. Filipe-Santos O, Bustamante J, Haverkamp MH et al. Xlinked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J ExpMed 2006;203:1745-59.
29. Orange JS, Brodeur SR, Jain A et al. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest 2002;109:1501-9.
30. Pandey R, DeStephan CM, Madge LA, May MJ, Orange JS. NKp30 ligation induces rapid activation of the canonical NF-kappaB pathway in NK cells. J Immunol 2007;179: 7385-96.
31. Tono C, Takahashi Y, Terui K et al. Correction of immunodeficiency associated with NEMO mutation by umbilical cord blood transplantation using a reduced-intensity conditioning regimen. Bone Marrow Transplant 2007;39: 801-4.
32. Fish JD, Duerst RE, Gelfand EW, Orange JS, Bunin N. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency. Bone Marrow Transplant 2009;43:217-21.
33. Mizukami T, Obara M, Nishikomori R et al. Successful treatment with infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency. J Clin Immunol 2012;32:39-49.
34. Nenci A, Becker C, Wullaert A et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007;446:557-61.
35. Orange JS, Levy O, Brodeur SR et al. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J Allergy Clin Immunol 2004;114:650-6.
36. Nishikomori R, Akutagawa H, Maruyama K et al. X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival. Blood 2004;103:4565-72.
37. Mooster JL, Cancrini C, Simonetti A et al. Immune deficiency caused by impaired expression of nuclear factorkappaB essential modifier (NEMO) because of a mutation in the 5' untranslated region of the NEMO gene. J Allergy Clin Immunol 2010;126:127-32.
38. Imamura M, Kawai T, Okada S et al. Disseminated BCG infection mimicking metastatic nasopharyngeal carcinoma in an immunodeficient child with a novel hypomorphic NEMO mutation. J Clin Immunol 2011;31:802-10.
39. Kawai T, Nishikomori R, Izawa K et al. Frequent somatic mosaicism of NEMO in T cells of patients with X-linked anhidrotic ectodermal dysplasia with immunodeficiency. Blood. Epub 2012 Apr 19.
40. Pai SY, Levy O, Jabara HH et al. Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factorkappaB essential modulator deficiency. J Allergy Clin Immunol 2008;122:1113-8.
41. Cheng LE, Kanwar B, Tcheurekdjian H et al. Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome. Clin Immunol 2009;132: 124-31.
42. Permaul P, Narla A, Hornick JL, Pai SY. Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia and immunodeficiency: case report and review of outcomes. Immunol Res 2009;44:89-98.
43. Dupuis-Girod S, Cancrini C, Le Deist F et al. Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency. Pediatrics 2006;118:e205-11.